We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

544 hedge funds and large institutions have $2.01B invested in iShares US Medical Devices ETF in 2023 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 152 increasing their positions, 224 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more call options, than puts

Call options by funds: $18.6M | Put options by funds: $12.7M

3.75% more ownership

Funds ownership: 35.74%39.49% (+3.8%)

7% less funds holding

Funds holding: 585544 (-41)

8% less capital invested

Capital invested by funds: $2.19B → $2.01B (-$185M)

32% less repeat investments, than reductions

Existing positions increased: 152 | Existing positions reduced: 224

40% less funds holding in top 10

Funds holding in top 10: 159 (-6)

46% less first-time investments, than exits

New positions opened: 43 | Existing positions closed: 80

Holders
544
Holders Change
-41
Holders Change %
-7.01%
% of All Funds
8.63%
Holding in Top 10
9
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-40%
% of All Funds
0.14%
New
43
Increased
152
Reduced
224
Closed
80
Calls
$18.6M
Puts
$12.7M
Net Calls
+$5.93M
Net Calls Change
+$11.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Cerity Partners
126
Cerity Partners
New York
$2.17M -$390K -7,341 -14%
SC
127
Scotia Capital
Ontario, Canada
$2.13M -$36.4K -684 -2%
GWM
128
Gray Wealth Management
Maine
$2.12M -$71.7K -1,349 -3%
Cetera Investment Advisers
129
Cetera Investment Advisers
Illinois
$2.11M +$104K +1,961 +5%
RHP
130
Royal Harbor Partners
Texas
$2.1M +$108K +2,027 +5%
TA
131
TruWealth Advisors
Louisiana
$2.07M -$22.2M -417,252 -91%
SFS
132
Sowell Financial Services
Arkansas
$2.03M -$102K -1,915 -4%
CAM
133
Cypress Asset Management
Texas
$2.03M +$63.8K +1,200 +3%
BCV
134
Banque Cantonale Vaudoise
Switzerland
$1.96M -$195K -3,660 -8%
MMA
135
Miracle Mile Advisors
California
$1.91M -$89.8K -1,689 -4%
Citigroup
136
Citigroup
New York
$1.89M +$1.07M +20,081 +106%
P
137
Palladiem
Pennsylvania
$1.86M -$15.7K -295 -0.8%
SWP
138
Stratos Wealth Partners
Ohio
$1.86M +$3.03K +57 +0.1%
WA
139
WESPAC Advisors
California
$1.81M -$30.3K -570 -2%
AIA
140
Armor Investment Advisors
North Carolina
$1.8M +$14.2K +268 +0.7%
TCMP
141
Thrive Capital Management (Pennsylvania)
Pennsylvania
$1.77M +$375K +7,045 +24%
CWM
142
Concentrum Wealth Management
California
$1.75M +$126K +2,361 +7%
VWM
143
Valley Wealth Managers
New Jersey
$1.73M +$1.9M +35,649 New
EFH
144
Eaton Financial Holdings
Florida
$1.72M +$8.99K +169 +0.5%
MBT
145
Montecito Bank & Trust
California
$1.71M -$62.4K -1,174 -3%
GS
146
GTS Securities
New York
$1.68M +$1.51M +28,309 +443%
PA
147
Parallel Advisors
California
$1.67M -$323K -6,072 -15%
PA
148
Pinnacle Associates
New York
$1.67M -$33.5K -630 -2%
SCA
149
Snowden Capital Advisors
New York
$1.65M -$1.16M -21,858 -39%
JWCA
150
J.W. Cole Advisors
Florida
$1.6M +$44.2K +832 +3%

IHI Hedge Fund Activity: Q3 2023 in Review

544 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q3 2023, worth a combined $2.01B — down 8.4% from $2.19B a quarter earlier.

Sellers outnumbered buyers: 80 funds closed out of IHI and 43 opened new positions — a net loss of 37 holders — while 224 trimmed existing stakes and 152 added.

The largest buyer was Bank of America, adding an estimated $50.2M. The largest seller was Morgan Stanley, cutting an estimated $34.4M.

  • 544 institutional investors held iShares US Medical Devices ETF (IHI) as of Q3 2023, down from 585 in Q2 2023.
  • Funds reported $2.01B of iShares US Medical Devices ETF stock for Q3 2023, down 8.4% quarter-over-quarter.
  • 43 funds opened new iShares US Medical Devices ETF positions in Q3 2023 and 80 closed out, a net change of -37 holders.
  • The largest iShares US Medical Devices ETF buyer in Q3 2023 was Bank of America, an estimated $50.2M added.
  • The largest iShares US Medical Devices ETF seller in Q3 2023 was Morgan Stanley, an estimated $34.4M sold.

Based on aggregated 13F filings for Q3 2023.